Skip to main content
Erschienen in: Inflammation 5/2013

01.10.2013

The Relationship Between N-acetylcysteine, Hyperbaric Oxygen, and Inflammation in a Rat Model of Acetaminophen-induced Nephrotoxicity

verfasst von: Hakan Cermik, Mine Yavuz Taslipinar, Ibrahim Aydin, Mehmet Agilli, Fevzi Nuri Aydin, Fatma Ucar, Bilal Firat Alp, Mehmet Toygar, Esin Ozkan, Ertan Altayli, Tuncer Cayci

Erschienen in: Inflammation | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

An overdose of acetaminophen (APAP) produces acute tubular necrosis. The aim of this study was to observe the effects of hyperbaric oxygen (HBO) only and combined with N-acetylcysteine (NAC) on inflammatory cytokines in kidney. Thirty-two male Sprague–Dawley rats were divided into four groups: sham, control (APAP), NAC, and NAC + HBO. In the APAP, NAC, and NAC + HBO groups, renal injury was induced by oral administration of 1 g/kg APAP. The NAC group received NAC (100 mg/kg/day). NAC + HBO group received NAC (100 mg/kg/day) intraperitoneally and HBO underwent at 2.8 ATA pressure with 100 % oxygen inhalation for 90 min every 12 h for 5 days. Rats in the sham group received distilled water only by gastric tube. All animals were killed on 6 days after APAP or distilled water administration. Creatinine, urea, neopterin, tumor necrosis factor-α (TNF-α), and interleukin (IL)-6 levels were measured in sera. There was a significant increase in serum creatinine and urea levels in the control group compared to the sham group (in both, p = 0.001). NAC and NAC + HBO significantly decreased serum neopterin, TNF-α, and IL-6 levels compared to control group. APAP administration caused tubular necrosis in the renal. NAC and NAC + HBO treatments significantly reduced APAP-induced renal damage. The results of this study showed that renal dysfunction in APAP toxicity was attenuated by the use of HBO and NAC treatments. The combination of NAC and HBO treatments might be recommended as an effective treatment modality for APAP-induced nephrotoxicity.
Literatur
1.
Zurück zum Zitat Cakir, E., O.E. Akgul, I. Aydin, T. Cayci, Y.G. Kurt, O. Onguru, F.N. Aydin, M. Agilli, H. Yaman, N. Ersoz, S. Bilgic, A. Guven, T. Turker, C. Bilgi, and K.M. Erbil. 2010. The association between neopterin and acetaminophen-induced nephrotoxicity. Renal Failure 32: 740–746.PubMedCrossRef Cakir, E., O.E. Akgul, I. Aydin, T. Cayci, Y.G. Kurt, O. Onguru, F.N. Aydin, M. Agilli, H. Yaman, N. Ersoz, S. Bilgic, A. Guven, T. Turker, C. Bilgi, and K.M. Erbil. 2010. The association between neopterin and acetaminophen-induced nephrotoxicity. Renal Failure 32: 740–746.PubMedCrossRef
2.
Zurück zum Zitat Demirbas, S., E. Cakir, E.O. Akgul, M. Seyrek, T. Cayci, Y.G. Kurt, B. Uysal, I. Aydin, B. Kurt, H. Yaman, and M.K. Erbil. 2011. Elevated serum neopterin levels in acetaminophen-induced liver injury. Environmental Toxicology and Pharmacology 31: 165–170.PubMedCrossRef Demirbas, S., E. Cakir, E.O. Akgul, M. Seyrek, T. Cayci, Y.G. Kurt, B. Uysal, I. Aydin, B. Kurt, H. Yaman, and M.K. Erbil. 2011. Elevated serum neopterin levels in acetaminophen-induced liver injury. Environmental Toxicology and Pharmacology 31: 165–170.PubMedCrossRef
3.
Zurück zum Zitat Gul, H., B. Uysal, E. Cakir, H. Yaman, E. Macit, A.O. Yildirim, Y.E. Eyi, U. Kaldirim, E. Oztas, E.O. Akgul, T. Cayci, M. Ozler, T. Topal, S. Oter, A. Korkmaz, M. Toygar, and S. Demirbag. 2012. The protective effects of ozone therapy in a rat model of acetaminophen-induced liver injury. Environmental Toxicology and Pharmacology 34: 81–86.PubMedCrossRef Gul, H., B. Uysal, E. Cakir, H. Yaman, E. Macit, A.O. Yildirim, Y.E. Eyi, U. Kaldirim, E. Oztas, E.O. Akgul, T. Cayci, M. Ozler, T. Topal, S. Oter, A. Korkmaz, M. Toygar, and S. Demirbag. 2012. The protective effects of ozone therapy in a rat model of acetaminophen-induced liver injury. Environmental Toxicology and Pharmacology 34: 81–86.PubMedCrossRef
4.
Zurück zum Zitat Yaman, H., S. Isbilir, E. Cakir, and B. Uysal. 2011. Current issues with paracetamol induced toxicity. Journal of Experimental and Integrative Medicine 1: 165–166.CrossRef Yaman, H., S. Isbilir, E. Cakir, and B. Uysal. 2011. Current issues with paracetamol induced toxicity. Journal of Experimental and Integrative Medicine 1: 165–166.CrossRef
5.
Zurück zum Zitat Salhanick, S.D., B. Belikoff, D. Orlow, D. Holt, W. Reenstra, and J.A. Buras. 2006. Hyperbaric oxygen reduces acetaminophen toxicity and increases HIF-1alpha expression. Academic Emergency Medicine 13: 707–714.PubMedCrossRef Salhanick, S.D., B. Belikoff, D. Orlow, D. Holt, W. Reenstra, and J.A. Buras. 2006. Hyperbaric oxygen reduces acetaminophen toxicity and increases HIF-1alpha expression. Academic Emergency Medicine 13: 707–714.PubMedCrossRef
6.
Zurück zum Zitat Atasoyu, E.M., S. Yildiz, M. Cimsit, H. Cermik, T. Qyrdedi, T.R. Evrenkaya, S. Aktas, G. Uzun, O. Bilgi, and M. Gultepe. 2006. Investigation of the effect of hyperbaric oxygen on experimental cyclosporine nephrotoxicity. Basic & Clinical Pharmacology & Toxicology 98: 150–154.CrossRef Atasoyu, E.M., S. Yildiz, M. Cimsit, H. Cermik, T. Qyrdedi, T.R. Evrenkaya, S. Aktas, G. Uzun, O. Bilgi, and M. Gultepe. 2006. Investigation of the effect of hyperbaric oxygen on experimental cyclosporine nephrotoxicity. Basic & Clinical Pharmacology & Toxicology 98: 150–154.CrossRef
7.
Zurück zum Zitat Tibbles, P.M., and J.S. Edelsberg. 1996. Hyperbaric-oxygen therapy. The New England Journal of Medicine 334: 1642–1648.PubMedCrossRef Tibbles, P.M., and J.S. Edelsberg. 1996. Hyperbaric-oxygen therapy. The New England Journal of Medicine 334: 1642–1648.PubMedCrossRef
8.
Zurück zum Zitat Atasoyu, E.M., S. Yildiz, O. Bilgi, H. Cermik, R. Evrenkaya, S. Aktas, M. Gultepe, and E.G. Kandemir. 2005. Investigation of the role of hyperbaric oxygen therapy in cisplatin-induced nephrotoxicity in rats. Archives of Toxicology 79: 289–293.PubMedCrossRef Atasoyu, E.M., S. Yildiz, O. Bilgi, H. Cermik, R. Evrenkaya, S. Aktas, M. Gultepe, and E.G. Kandemir. 2005. Investigation of the role of hyperbaric oxygen therapy in cisplatin-induced nephrotoxicity in rats. Archives of Toxicology 79: 289–293.PubMedCrossRef
9.
Zurück zum Zitat Yasar, M., S. Yildiz, R. Mas, K. Dundar, A. Yildirim, A. Korkmaz, C. Akay, N. Kaymakcioglu, T. Ozisik, and D. Sen. 2003. The effect of hyperbaric oxygen treatment on oxidative stress in experimental acute necrotizing pancreatitis. Physiological Research 52: 111–116.PubMed Yasar, M., S. Yildiz, R. Mas, K. Dundar, A. Yildirim, A. Korkmaz, C. Akay, N. Kaymakcioglu, T. Ozisik, and D. Sen. 2003. The effect of hyperbaric oxygen treatment on oxidative stress in experimental acute necrotizing pancreatitis. Physiological Research 52: 111–116.PubMed
10.
Zurück zum Zitat Chen, M.F., H.M. Chen, S.W. Ueng, and M.H. Shyr. 1998. Hyperbaric oxygen pretreatment attenuates hepatic reperfusion injury. Liver 18: 110–116.PubMed Chen, M.F., H.M. Chen, S.W. Ueng, and M.H. Shyr. 1998. Hyperbaric oxygen pretreatment attenuates hepatic reperfusion injury. Liver 18: 110–116.PubMed
11.
Zurück zum Zitat Edremitlioglu, M., D. Kilic, S. Oter, U. Kisa, A. Korkmaz, O. Coskun, and O. Bedir. 2005. The effect of hyperbaric oxygen treatment on the renal functions in septic rats: relation to oxidative damage. Surgery Today 35: 653–661.PubMedCrossRef Edremitlioglu, M., D. Kilic, S. Oter, U. Kisa, A. Korkmaz, O. Coskun, and O. Bedir. 2005. The effect of hyperbaric oxygen treatment on the renal functions in septic rats: relation to oxidative damage. Surgery Today 35: 653–661.PubMedCrossRef
12.
Zurück zum Zitat Yeh, C.H., Z.C. Chen, C.C. Hsu, M.T. Lin, and C.C. Chen. 2010. Protection in rats with heatstroke: hyperbaric oxygen vs activated protein C therapy. European Journal of Pharmacology 635: 103–108.PubMedCrossRef Yeh, C.H., Z.C. Chen, C.C. Hsu, M.T. Lin, and C.C. Chen. 2010. Protection in rats with heatstroke: hyperbaric oxygen vs activated protein C therapy. European Journal of Pharmacology 635: 103–108.PubMedCrossRef
13.
Zurück zum Zitat Al-Waili, N.S., G.J. Butler, B.Y. Lee, Z. Carrey, and R. Petrillo. 2009. Possible application of hyperbaric oxygen technology in the management of urogenital and renal diseases. Journal of Medical Engineering & Technology 33: 507–515.CrossRef Al-Waili, N.S., G.J. Butler, B.Y. Lee, Z. Carrey, and R. Petrillo. 2009. Possible application of hyperbaric oxygen technology in the management of urogenital and renal diseases. Journal of Medical Engineering & Technology 33: 507–515.CrossRef
14.
Zurück zum Zitat Al-Waili, N.S., and G.J. Butler. 2006. Effects of hyperbaric oxygen on inflammatory response to wound and trauma: possible mechanism of action. The Scientific World Journal 6: 425–441.CrossRef Al-Waili, N.S., and G.J. Butler. 2006. Effects of hyperbaric oxygen on inflammatory response to wound and trauma: possible mechanism of action. The Scientific World Journal 6: 425–441.CrossRef
15.
Zurück zum Zitat Rinaldi, B., S. Cuzzocrea, M. Donniacuo, A. Capuano, D. Di Palma, F. Imperatore, E. Mazzon, R. Di Paola, L. Sodano, and F. Rossi. 2011. Hyperbaric oxygen therapy reduces the toll-like receptor signaling pathway in multiple organ failures. Intensive Care Medicine 37: 1110–1119.PubMedCrossRef Rinaldi, B., S. Cuzzocrea, M. Donniacuo, A. Capuano, D. Di Palma, F. Imperatore, E. Mazzon, R. Di Paola, L. Sodano, and F. Rossi. 2011. Hyperbaric oxygen therapy reduces the toll-like receptor signaling pathway in multiple organ failures. Intensive Care Medicine 37: 1110–1119.PubMedCrossRef
16.
Zurück zum Zitat Jain, K.K. 2004. Drug interactions with hyperbaric oxygen. In Textbook of hyperbaric oxygen, ed. K.K. Jain, 80–82. Cambridge: Hogrefe-Huber Publishers. Jain, K.K. 2004. Drug interactions with hyperbaric oxygen. In Textbook of hyperbaric oxygen, ed. K.K. Jain, 80–82. Cambridge: Hogrefe-Huber Publishers.
17.
Zurück zum Zitat Caglikulekci, M., C. Pata, D.D. Apa, M. Dirlik, L. Tamer, F. Yaylak, A. Kanik, and S. Aydin. 2004. The effect of N-acetylcysteine (NAC) on liver and renal tissue inducible nitric oxide synthase (iNOS) and tissue lipid peroxidation in obstructive jaundice stimulated by lipopolysaccharide (LPS). Pharmacological Research 49: 227–238.PubMedCrossRef Caglikulekci, M., C. Pata, D.D. Apa, M. Dirlik, L. Tamer, F. Yaylak, A. Kanik, and S. Aydin. 2004. The effect of N-acetylcysteine (NAC) on liver and renal tissue inducible nitric oxide synthase (iNOS) and tissue lipid peroxidation in obstructive jaundice stimulated by lipopolysaccharide (LPS). Pharmacological Research 49: 227–238.PubMedCrossRef
18.
Zurück zum Zitat Hsu, B.G., R.P. Lee, F.L. Yang, H.J. Harn, and H.I. Chen. 2006. Post-treatment with N-acetylcysteine ameliorates endotoxin shock-induced organ damage in conscious rats. Life Sciences 79: 2010–2016.PubMedCrossRef Hsu, B.G., R.P. Lee, F.L. Yang, H.J. Harn, and H.I. Chen. 2006. Post-treatment with N-acetylcysteine ameliorates endotoxin shock-induced organ damage in conscious rats. Life Sciences 79: 2010–2016.PubMedCrossRef
19.
Zurück zum Zitat Hsu, B.G., F.L. Yang, R.P. Lee, T.C. Peng, H.J. Harn, and H.I. Chen. 2004. N-acetylcysteine ameliorates lipopolysaccharide-induced organ damage in conscious rats. Journal of Biomedical Science 11: 152–162.PubMedCrossRef Hsu, B.G., F.L. Yang, R.P. Lee, T.C. Peng, H.J. Harn, and H.I. Chen. 2004. N-acetylcysteine ameliorates lipopolysaccharide-induced organ damage in conscious rats. Journal of Biomedical Science 11: 152–162.PubMedCrossRef
20.
Zurück zum Zitat Altinel, O., S. Demirbas, E. Cakir, H. Yaman, I.H. Ozerhan, E. Duran, T. Cayci, E.O. Akgul, N. Ersoz, B. Uysal, B. Kurt, M. Yasar, S. Oter, and Y. Peker. 2011. Comparison of hyperbaric oxygen and medical ozone therapies in a rat model of experimental distal colitis. Scandinavian Journal of Clinical and Laboratory Investigation 71: 185–192.PubMedCrossRef Altinel, O., S. Demirbas, E. Cakir, H. Yaman, I.H. Ozerhan, E. Duran, T. Cayci, E.O. Akgul, N. Ersoz, B. Uysal, B. Kurt, M. Yasar, S. Oter, and Y. Peker. 2011. Comparison of hyperbaric oxygen and medical ozone therapies in a rat model of experimental distal colitis. Scandinavian Journal of Clinical and Laboratory Investigation 71: 185–192.PubMedCrossRef
21.
Zurück zum Zitat Yaman, H., E. Cakir, O. Ozcan, Z. Yesilova, A. Ozcan, E.O. Akgul, M.K. Erbil, S. Bagci, C. Bilgi, and K. Dagalp. 2005. Elevated urine neopterin levels in nonalcoholic steatohepatitis. Clinical Biochemistry 38: 187–190.PubMedCrossRef Yaman, H., E. Cakir, O. Ozcan, Z. Yesilova, A. Ozcan, E.O. Akgul, M.K. Erbil, S. Bagci, C. Bilgi, and K. Dagalp. 2005. Elevated urine neopterin levels in nonalcoholic steatohepatitis. Clinical Biochemistry 38: 187–190.PubMedCrossRef
22.
Zurück zum Zitat Agilli, M., H. Yaman, T. Cayci, I. Sener, M. Oztosun, I. Aydin, F.N. Aydin, Y.G. Kurt, E. Cakir, and E.O. Akgul. 2012. Comparison of two different HPLC methods and Elisa method for measurement of serum neopterin. Journal of Investigational Biochemistry 1: 43–47.CrossRef Agilli, M., H. Yaman, T. Cayci, I. Sener, M. Oztosun, I. Aydin, F.N. Aydin, Y.G. Kurt, E. Cakir, and E.O. Akgul. 2012. Comparison of two different HPLC methods and Elisa method for measurement of serum neopterin. Journal of Investigational Biochemistry 1: 43–47.CrossRef
23.
Zurück zum Zitat Yamanel, L., U. Kaldirim, Y. Oztas, O. Coskun, Y. Poyrazoglu, M. Durusu, T. Cayci, A. Ozturk, S. Demirbas, M. Yasar, O. Cinar, S.K. Tuncer, Y.E. Eyi, B. Uysal, T. Topal, S. Oter, and A. Korkmaz. 2011. Ozone therapy and hyperbaric oxygen treatment in lung injury in septic rats. International Journal of Medical Sciences 8: 48–55.PubMedCrossRef Yamanel, L., U. Kaldirim, Y. Oztas, O. Coskun, Y. Poyrazoglu, M. Durusu, T. Cayci, A. Ozturk, S. Demirbas, M. Yasar, O. Cinar, S.K. Tuncer, Y.E. Eyi, B. Uysal, T. Topal, S. Oter, and A. Korkmaz. 2011. Ozone therapy and hyperbaric oxygen treatment in lung injury in septic rats. International Journal of Medical Sciences 8: 48–55.PubMedCrossRef
24.
Zurück zum Zitat van der Poll, T., and S.J. van Deventer. 1999. Cytokines and anticytokines in the pathogenesis of sepsis. Infectious Disease Clinics of North America 13: 413–426.PubMedCrossRef van der Poll, T., and S.J. van Deventer. 1999. Cytokines and anticytokines in the pathogenesis of sepsis. Infectious Disease Clinics of North America 13: 413–426.PubMedCrossRef
25.
Zurück zum Zitat Ruokonen, E., L. Ilkka, M. Niskanen, and J. Takala. 2002. Procalcitonin and neopterin as indicators of infection in critically ill patients. Acta Anaesthesiologica Scandinavica 46: 398–404.PubMedCrossRef Ruokonen, E., L. Ilkka, M. Niskanen, and J. Takala. 2002. Procalcitonin and neopterin as indicators of infection in critically ill patients. Acta Anaesthesiologica Scandinavica 46: 398–404.PubMedCrossRef
26.
Zurück zum Zitat Weisz, G., A. Lavy, Y. Adir, Y. Melamed, D. Rubin, S. Eidelman, and S. Pollack. 1997. Modification of in vivo and in vitro TNF-alpha, IL-1, and IL-6 secretion by circulating monocytes during hyperbaric oxygen treatment in patients with perianal Crohn’s disease. Journal of Clinical Immunology 17: 154–159.PubMedCrossRef Weisz, G., A. Lavy, Y. Adir, Y. Melamed, D. Rubin, S. Eidelman, and S. Pollack. 1997. Modification of in vivo and in vitro TNF-alpha, IL-1, and IL-6 secretion by circulating monocytes during hyperbaric oxygen treatment in patients with perianal Crohn’s disease. Journal of Clinical Immunology 17: 154–159.PubMedCrossRef
27.
Zurück zum Zitat Nandi, J., B. Saud, J.M. Zinkievich, Z.J. Yang, and R.A. Levine. 2010. TNF-alpha modulates iNOS expression in an experimental rat model of indomethacin-induced jejunoileitis. Molecular and Cellular Biochemistry 336: 17–24.PubMedCrossRef Nandi, J., B. Saud, J.M. Zinkievich, Z.J. Yang, and R.A. Levine. 2010. TNF-alpha modulates iNOS expression in an experimental rat model of indomethacin-induced jejunoileitis. Molecular and Cellular Biochemistry 336: 17–24.PubMedCrossRef
28.
Zurück zum Zitat Lahat, N., H. Bitterman, N. Yaniv, A. Kinarty, and N. Bitterman. 1995. Exposure to hyperbaric oxygen induces tumour necrosis factor-alpha (TNF-alpha) secretion from rat macrophages. Clinical and Experimental Immunology 102: 655–659.PubMedCrossRef Lahat, N., H. Bitterman, N. Yaniv, A. Kinarty, and N. Bitterman. 1995. Exposure to hyperbaric oxygen induces tumour necrosis factor-alpha (TNF-alpha) secretion from rat macrophages. Clinical and Experimental Immunology 102: 655–659.PubMedCrossRef
29.
Zurück zum Zitat Benson, R.M., L.M. Minter, B.A. Osborne, and E.V. Granowitz. 2003. Hyperbaric oxygen inhibits stimulus-induced proinflammatory cytokine synthesis by human blood-derived monocyte-macrophages. Clinical and Experimental Immunology 134: 57–62.PubMedCrossRef Benson, R.M., L.M. Minter, B.A. Osborne, and E.V. Granowitz. 2003. Hyperbaric oxygen inhibits stimulus-induced proinflammatory cytokine synthesis by human blood-derived monocyte-macrophages. Clinical and Experimental Immunology 134: 57–62.PubMedCrossRef
30.
Zurück zum Zitat Pan, H.C., C.S. Chin, D.Y. Yang, S.P. Ho, C.J. Chen, S.M. Hwang, M.H. Chang, and F.C. Cheng. 2009. Human amniotic fluid mesenchymal stem cells in combination with hyperbaric oxygen augment peripheral nerve regeneration. Neurochemical Research 34: 1304–1316.PubMedCrossRef Pan, H.C., C.S. Chin, D.Y. Yang, S.P. Ho, C.J. Chen, S.M. Hwang, M.H. Chang, and F.C. Cheng. 2009. Human amniotic fluid mesenchymal stem cells in combination with hyperbaric oxygen augment peripheral nerve regeneration. Neurochemical Research 34: 1304–1316.PubMedCrossRef
31.
Zurück zum Zitat Granowitz, E.V., E.J. Skulsky, R.M. Benson, J. Wright, J.L. Garb, E.R. Cohen, E.C. Smithline, and R.B. Brown. 2002. Exposure to increased pressure or hyperbaric oxygen suppresses interferon-gamma secretion in whole blood cultures of healthy humans. Undersea & Hyperbaric Medicine 29: 216–225. Granowitz, E.V., E.J. Skulsky, R.M. Benson, J. Wright, J.L. Garb, E.R. Cohen, E.C. Smithline, and R.B. Brown. 2002. Exposure to increased pressure or hyperbaric oxygen suppresses interferon-gamma secretion in whole blood cultures of healthy humans. Undersea & Hyperbaric Medicine 29: 216–225.
32.
Zurück zum Zitat Choudhury, D., and M. Levi. 2011. Kidney aging—inevitable or preventable? Nature Reviews Nephrology 7: 706–717.PubMedCrossRef Choudhury, D., and M. Levi. 2011. Kidney aging—inevitable or preventable? Nature Reviews Nephrology 7: 706–717.PubMedCrossRef
33.
Zurück zum Zitat Spapen, H., H. Zhang, C. Demanet, W. Vleminckx, J.L. Vincent, and L. Huyghens. 1998. Does N-acetyl-l-cysteine influence cytokine response during early human septic shock? Chest 113: 1616–1624.PubMedCrossRef Spapen, H., H. Zhang, C. Demanet, W. Vleminckx, J.L. Vincent, and L. Huyghens. 1998. Does N-acetyl-l-cysteine influence cytokine response during early human septic shock? Chest 113: 1616–1624.PubMedCrossRef
34.
Zurück zum Zitat Zafarullah, M., W.Q. Li, J. Sylvester, and M. Ahmad. 2003. Molecular mechanisms of N-acetylcysteine actions. Cellular and Molecular Life Sciences 60: 6–20.PubMedCrossRef Zafarullah, M., W.Q. Li, J. Sylvester, and M. Ahmad. 2003. Molecular mechanisms of N-acetylcysteine actions. Cellular and Molecular Life Sciences 60: 6–20.PubMedCrossRef
35.
Zurück zum Zitat Luo, J., T. Tsuji, H. Yasuda, Y. Sun, Y. Fujigaki, and A. Hishida. 2008. The molecular mechanisms of the attenuation of cisplatin-induced acute renal failure by N-acetylcysteine in rats. Nephrology, Dialysis, Transplantation 23: 2198–2205.PubMedCrossRef Luo, J., T. Tsuji, H. Yasuda, Y. Sun, Y. Fujigaki, and A. Hishida. 2008. The molecular mechanisms of the attenuation of cisplatin-induced acute renal failure by N-acetylcysteine in rats. Nephrology, Dialysis, Transplantation 23: 2198–2205.PubMedCrossRef
36.
Zurück zum Zitat Mishima, K., A. Baba, M. Matsuo, Y. Itoh, and R. Oishi. 2006. Protective effect of cyclic AMP against cisplatin-induced nephrotoxicity. Free Radical Biology & Medicine 40: 1564–1577.CrossRef Mishima, K., A. Baba, M. Matsuo, Y. Itoh, and R. Oishi. 2006. Protective effect of cyclic AMP against cisplatin-induced nephrotoxicity. Free Radical Biology & Medicine 40: 1564–1577.CrossRef
37.
Zurück zum Zitat Shalby, A.B., N. Assaf, and H.H. Ahmed. 2011. Possible mechanisms for N-acetyl cysteine and taurine in ameliorating acute renal failure induced by cisplatin in rats. Toxicology Mechanisms and Methods 21: 538–546.PubMedCrossRef Shalby, A.B., N. Assaf, and H.H. Ahmed. 2011. Possible mechanisms for N-acetyl cysteine and taurine in ameliorating acute renal failure induced by cisplatin in rats. Toxicology Mechanisms and Methods 21: 538–546.PubMedCrossRef
38.
Zurück zum Zitat Abdel-Zaher, A.O., R.H. Abdel-Hady, M.M. Mahmoud, and M.M. Farrag. 2008. The potential protective role of alpha-lipoic acid against acetaminophen-induced hepatic and renal damage. Toxicology 243: 261–270.PubMedCrossRef Abdel-Zaher, A.O., R.H. Abdel-Hady, M.M. Mahmoud, and M.M. Farrag. 2008. The potential protective role of alpha-lipoic acid against acetaminophen-induced hepatic and renal damage. Toxicology 243: 261–270.PubMedCrossRef
39.
Zurück zum Zitat Abraham, P. 2005. Vitamin C may be beneficial in the prevention of paracetamol-induced renal damage. Clinical and Experimental Nephrology 9: 24–30.PubMedCrossRef Abraham, P. 2005. Vitamin C may be beneficial in the prevention of paracetamol-induced renal damage. Clinical and Experimental Nephrology 9: 24–30.PubMedCrossRef
Metadaten
Titel
The Relationship Between N-acetylcysteine, Hyperbaric Oxygen, and Inflammation in a Rat Model of Acetaminophen-induced Nephrotoxicity
verfasst von
Hakan Cermik
Mine Yavuz Taslipinar
Ibrahim Aydin
Mehmet Agilli
Fevzi Nuri Aydin
Fatma Ucar
Bilal Firat Alp
Mehmet Toygar
Esin Ozkan
Ertan Altayli
Tuncer Cayci
Publikationsdatum
01.10.2013
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 5/2013
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-013-9649-4

Weitere Artikel der Ausgabe 5/2013

Inflammation 5/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.